Reciprocal role of vasculogenic factors and progenitor cells in atherogenesis

Handbook of Experimental Pharmacology

Volumn 170, Issue , 2005, Pages 777-783

  MurayaM A , T ^a   Tepper, O M ^b   Asahara, T ^c  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c RIKEN Center for Biosystems Dynamics Research   (Japan)

Author keywords

Atherosclerosis; Endothelial progenitor cells; Neovascularization; Vascular injury

Indexed keywords

ANGIOGENESIS; ANIMAL; ATHEROSCLEROSIS; CYTOLOGY; ENDOTHELIUM CELL; HUMAN; PHYSIOLOGY; REVIEW; STEM CELL;

ANIMALS; ATHEROSCLEROSIS; ENDOTHELIAL CELLS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELLS;

EID: 33645792633     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/3-540-27661-0-29     Document Type: Article

References (29)

1. Altschul R (1954) Endothelium, its development, morphology, function, and Pathology. Macmillan, New York
2. Asahara T, Bauters C, Pastore C, Kearney M, Rossow S, Bunting S, Ferrara N, Symes JF, Isner JM (1995) Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation 91:2793-2801
3. Asahara T, Chen D, Tsurumi Y, Kearney M, Rossow S, Passeri J, Symes JF, Isner JM (1996) Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer. Circulation 94:3291-3302
4. AsaharaT,MuroharaT, Sullivan A, Silver M, van derZeeR, LiT,WitzenbichlerB, Schatteman G, Isner JM (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967
5. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM (1999) Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85:221-228
6. Baumgartner I, Pieczek A, Manor O, Blair R, Kearney M, Walsh K, Isner JM (1998) Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 97:1114-1123
7. Celletti FL,Hilfiker PR, Ghafouri P, DakeMD(2001a) Effect of human recombinant vascular endothelial growth factor165 on progression of atherosclerotic plaque. JAmColl Cardiol 37:2126-2130
8. Celletti FL,Waugh JM,Amabile PG,Brendolan A,HilfikerPR, DakeMD(2001b)Vascular endothelial growth factor enhances atherosclerotic plaque progression.NatMed 7:425-429
9. Folkman J (1993) Tumor angiogenesis. In: Holland J, Frei EI, Bast RJ, Kute D, Morton D, Weichselbaum R (eds) Cancer medicine. Lea & Febiger, Philadelphia, pp 153-170
10. GillM,Dias S,Hattori K, Rivera ML,Hicklin D, Witte L, Girardi L, Yurt R, HimelH, Rafii S (2001)Vascular traumainduces rapidbut transientmobilizationofVEGFR2(+)AC133(+) endothelial precursor cells. Circ Res 88:167-174
11. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348:593-600
12. HiltunenMO, Laitinen M, Turunen MP, Jeltsch M, Hartikainen J, Rissanen TT, Laukkanen J, Niemi M,Kossila M,Hakkinen TP,Kivela A, Enholm B,Mansukoski H, Turunen AM, Alitalo K, Yla-Herttuala S (2000) Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta. Circulation 102:2262-2268
13. Isner JM (1998) Arterial gene transfer of naked DNA for therapeutic angiogenesis: early clinical results. Adv Drug Deliv Rev 30:185-197
14. Isner JM (1999) Cancer and atherosclerosis: the broad mandate of angiogenesis. Circulation 99:1653-1655
15. Isner JM (2001) Still more debate over VEGF. Nat Med 7:639-641
16. Iwaguro H, Yamaguchi J, Kalka C, Murasawa S, Masuda H, Hayashi S, Silver M, Li T, Isner JM,Asahara T (2002) Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 105:732-738
17. Losordo DW, Isner JM (2001) Vascular endothelial growth factor-induced angiogenesis: crouching tiger or hidden dragon? J Am Coll Cardiol 37:2131-2135
18. Moulton KS, Heller E, Konerding MA, Flynn E, PalinskiW, Folkman J (1999) Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 99:1726-1732
19. Moulton KS, Vakili K, Zurakowski D, Soliman M, Butterfield C, Sylvin E, Lo KM, Gillies S, Javaherian K, Folkman J (2003) Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci USA 100:4736-4741
20. Murasawa S, Llevadot J, Silver M, Isner JM, Losordo DW, Asahara T (2002) Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells. Circulation 106:1133-1139
21. Murayama T,KalkaC, SilverM,MaH,Asahara T (2001)Aging impairs therapeutic contribution of human endothelial progenitor cells to postnatal neovascularization. Circulation 104:II-68-69
22. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, Wang T, Gregg D, Ramaswami P, Pippen AM, Annex BH, Dong C, Taylor DA (2003) Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 108:457-463
23. Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, Katoh A, Sasaki K, Shimada T, Oike Y, Imaizumi T (2001) Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103:2776-2779
24. Van Belle E, Maillard L, Tio FO, Isner JM (1997a) Accelerated endothelialization by local delivery of recombinant human vascular endothelial growth factor reduces in-stent intimal formation. Biochem Biophys Res Commun 235:311-316
25. Van Belle E, Tio FO, ChenD,Maillard L, Kearney M, Isner JM (1997b) Passivation of metallic stents after arterial gene transfer of phVEGF165 inhibits thrombus formation and intimal thickening. J Am Coll Cardiol 29:1371-1379
26. Van Belle E, Tio FO, Couffinhal T, Maillard L, Passeri J, Isner JM (1997c) Stent endothelialization. Time course, impact of local catheter delivery, feasibility of recombinant protein administration, and response to cytokine expedition. Circulation 95:438-448
27. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S (2001) Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89:E1-7
28. Walter DH, Rittig K, Bahlmann FH, Kirchmair R, Silver M, Murayama T, Nishimura H, Losordo DW, Asahara T, Isner JM (2002) Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105:3017-3024
29. Werner N, Priller J, Laufs U, Endres M, Bohm M, Dirnagl U, Nickenig G (2002) Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3- methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol 22:1567-1572